Kathryn Tucker
-
Right to Try (RTT) Laws: A Battle with Multiple Fronts
By: Kathryn Tucker, JD[1] Background We have been leading efforts to open access to the investigational psychedelic drug psilocybin for…
-
Update re AIMS et al. v. DEA: DEA Doubles Down in Denying Dying Patients Access to Psilocybin
By Kathryn Tucker, JD[1] In January 2021, Dr. Sunil Aggarwal, a respected palliative care physician and founder of the Advanced…
-
At DEA’s Door: The Battle to Open Access to Psilocybin Therapy for Peace and Comfort at the End of Life
By Kathryn Tucker, JD[1] On Mother’s Day 2022, my client Erinn Baldeschwiler, a young mother of two with Stage IV…
-
FREE Virtual Event Series – Deep Dive Into the Oregon Psilocybin Services Act: Federal Law Issues (Session 5)
Emerge Law Group is continuing its FREE virtual event series “Deep Dive Into the Oregon Psilocybin Services Act“! Session 5: Federal…
-
The Intersection of End of Life Issues and the Oregon Psilocybin Services Act
Oregon’s Psilocybin Services Act (“PSA”) is the first state law legalizing access to psilocybin for adults. Psilocybin remains illegal to…
-
Efforts to Open Access to Psilocybin for Therapeutic Use with Those with Life Threatening Illness Continue
Emerge Law Group Special Counsel Kathryn Tucker submitted a Freedom of Information Act (“FOIA“) request to the Drug Enforcement Administration…
-
Four Organizations Dedicated to Disability and Patient Rights Join in the Fight for Terminally Ill Californians with Physical Disabilities
Our advocacy on behalf of Californians with terminal illnesses involving progressive loss of physical ability has been joined by a…
-
Fighting for Terminally Ill Californians with Physical Disabilities
Our advocacy on behalf of Californians with terminal illnesses involving progressive loss of physical ability continues. The case was filed…
-
Establishing a Pathway to Access Psilocybin for Use with Patients with Advanced Illness: UPDATE
As counsel to Dr. Sunil Aggarwal of the Advanced Integrative Medical Science (“AIMS”) Institute we have been seeking authorization for…
-
Landmark Petition to Reschedule Psilocybin filed with DEA
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on…
-
Ninth Circuit ducks merits in nation’s first legal challenge to allow access to psilocybin in end-of-life care under “Right-To-Try” laws
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research…
-
Why I Do What I Do: Representing patients with advanced illness
I represent Erinn Baldeschwiler in AIMS et al v DEA. Erinn is faced with advanced cancer, and the prospect of…
-
Psilocybin Therapy for Patients with Advanced Illness in Oregon
One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who…
-
Court Hears Argument in Landmark Case Seeking to Open Access to Psilocybin Therapy
Nation’s First Legal Challenge to Allow Psilocybin Therapy in End-of-Life Care Under “Right-To-Try” Law Heard by the Ninth Circuit Court…
-
California’s Aid in Dying Law Challenged in Federal Court for Discriminating Against Terminally Ill Patients with Physical Disabilities
Read Mercury News Article here: When the Aid-In-Dying Law Leaves You Out A number of Californians with terminal illnesses involving…
-
Petitioners’ Reply Brief Filed, Briefing Now Complete in AIMS et al v DEA
On Friday, 7/23, Petitioners filed their Reply Brief with the Ninth Circuit Court of Appeals in AIMS et al v…
-
Amici Curiae Supporting Case Seeking to Compel DEA to Allow Access to Psilocybin Therapy for Seriously Ill Patients
A Seattle palliative care physician, co-director of an integrative oncology clinic, and a number of his patients with advanced cancer…
-
Opening Access to Psilocybin Therapy for Seriously Ill Patients: The Petitioners’ Opening Brief in AIMS et al v DEA
Emerge Law Group is proud to represent a Seattle palliative care physician and co-director of an integrative oncology clinic, and…
-
Avenues to Access Psilocybin Therapy in Oregon, a New Palliative Care Tool for Patients Suffering Anxiety and Depression
By Kathryn L. Tucker, JD* Recent medical research is establishing the powerful therapeutic uses of psilocybin in the treatment of…
-
Nation’s First Legal Challenge to Allow Psilocybin Therapy in End-of-Life Care Under “Right-To-Try” Laws Moves Forward
On behalf of terminally ill patients suffering anxiety and depression, we announce an advocacy effort to open access to psilocybin…
-
Cooperative Federalism Returns with the Biden Administration: Implications for Cannabis as well as Psilocbyin
In November 2020, Oregon voters approved a first of its kind initiative to make psilocybin therapy legal under Oregon state…
-
Opening access to psilocybin therapy for those with life-threatening illnesses
Multiple recently conducted clinical trials show that therapy with psilocybin for relief of anxiety and depression in patients with advanced…